MarketPeel
Insider Trading Intelligence
JH

Janet Jill Hopkins

AURA
CHIEF MEDICAL OFFICER · AURA BIOSCIENCES, INC. · CIK 0001997710
FILING MIX · LIFETIME67%/33%
BUYS
8
SELLS
4
TOTAL VALUE
$326.3K
COMPANIES
1
ACTIVE SINCE
Nov 2023
HOLDINGS NOW
160,944
AVG SELL PX
$6.29
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 7 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Janet Jill Hopkins, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%+0.13%-0.03%+0.15%-1.24%
14d4+25.00%+7.45%-0.30%+7.75%+7.21%
30d4+50.00%+4.98%-2.59%+7.57%+5.01%
60d4+75.00%-3.70%-0.95%-2.75%-14.46%
90d4+50.00%+1.98%+3.18%-1.20%-9.09%
180d4(1 pending)+66.67%-2.24%+6.24%-8.48%-18.07%
1y4(2 pending)+100.00%-37.46%+12.76%-50.22%-50.22%
2y4(4 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
AURA · 160,944 shares · as of Mar 2, 2026
080,335160,670241,005321,340202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 8 buys / 4 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
89,056321,340Mar 2, 2026Mar 3, 2026View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
160,944160,944Mar 2, 2026Mar 3, 2026View →
AURA
AURA BIOSCIENCES, INC.
SALE
Chief Medical Officer
20,401$5.06$103.2K232,284Feb 17, 2026Feb 17, 2026View →
AURA
AURA BIOSCIENCES, INC.
SALE
Chief Medical Officer
17,109$5.42$92.7K252,685Nov 17, 2025Nov 17, 2025View →
AURA
AURA BIOSCIENCES, INC.
SALE
Chief Medical Officer
2,534$7.75$19.6K269,794Feb 18, 2025Feb 18, 2025View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
79,36579,365Feb 3, 2025Feb 4, 2025View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
120,635272,328Feb 3, 2025Feb 4, 2025View →
AURA
AURA BIOSCIENCES, INC.
SALE
Chief Medical Officer
11,822$9.36$110.7K151,693Nov 18, 2024Nov 18, 2024View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
41,48541,485Feb 1, 2024Feb 2, 2024View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
28,515163,515Feb 1, 2024Feb 2, 2024View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
200,000200,000Nov 1, 2023Nov 3, 2023View →
AURA
AURA BIOSCIENCES, INC.
PURCHASEGRANT
Stock grant
135,000135,000Nov 1, 2023Nov 3, 2023View →
Other insiders · AURA
Loading peer insiders…
About this filer
CIK 0001997710
ROLE
Chief Medical Officer
PRIMARY
AURA
COMPANIES
1
ACTIVE SINCE
Nov 2023
MARKETPEEL · /INSIDER/0001997710DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback